369 related articles for article (PubMed ID: 31244935)
1. CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes/macrophages.
Jiang P; Gao W; Ma T; Wang R; Piao Y; Dong X; Wang P; Zhang X; Liu Y; Su W; Xiang R; Zhang J; Li N
Theranostics; 2019; 9(10):2950-2966. PubMed ID: 31244935
[No Abstract] [Full Text] [Related]
2. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
[TBL] [Abstract][Full Text] [Related]
3. CD137-CD137L Signaling Affects Angiogenesis by Mediating Phenotypic Conversion of Macrophages.
Xu Y; Yan Y; Geng T; Wang C; Xu Y; Yang P; Yan J
J Cardiovasc Pharmacol; 2020 Feb; 75(2):148-154. PubMed ID: 31651672
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
[TBL] [Abstract][Full Text] [Related]
5. CD137L- and RANKL-mediated reverse signals inhibit osteoclastogenesis and T lymphocyte proliferation.
Senthilkumar R; Lee HW
Immunobiology; 2009; 214(2):153-61. PubMed ID: 19167994
[TBL] [Abstract][Full Text] [Related]
6. microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.
Cai WL; Huang WD; Li B; Chen TR; Li ZX; Zhao CL; Li HY; Wu YM; Yan WJ; Xiao JR
Mol Cancer; 2018 Jan; 17(1):9. PubMed ID: 29343249
[TBL] [Abstract][Full Text] [Related]
7. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y
Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790
[TBL] [Abstract][Full Text] [Related]
8. CD137-CD137L interaction modulates neointima formation and the phenotype transformation of vascular smooth muscle cells via NFATc1 signaling.
Zhong W; Li B; Yang P; Chen R; Wang C; Wang Z; Shao C; Yuan W; Yan J
Mol Cell Biochem; 2018 Feb; 439(1-2):65-74. PubMed ID: 28770466
[TBL] [Abstract][Full Text] [Related]
9. Identification of CD137- and CD137L-Expressing Cells in EL-4 Tumor.
Kang SW; Cho HR; Kwon B
Methods Mol Biol; 2021; 2248():221-229. PubMed ID: 33185879
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand.
Kang SW; Lee SC; Park SH; Kim J; Kim HH; Lee HW; Seo SK; Kwon BS; Cho HR; Kwon B
Cancer Res; 2017 Nov; 77(21):5989-6000. PubMed ID: 28923858
[TBL] [Abstract][Full Text] [Related]
11. Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells.
Tu Q; Zhang J; Fix A; Brewer E; Li YP; Zhang ZY; Chen J
J Cell Physiol; 2009 Jan; 218(1):135-45. PubMed ID: 18756497
[TBL] [Abstract][Full Text] [Related]
12. CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems.
Liverani C; Mercatali L; Spadazzi C; La Manna F; De Vita A; Riva N; Calpona S; Ricci M; Bongiovanni A; Gunelli E; Zanoni M; Fabbri F; Zoli W; Amadori D; Ibrahim T
Bone; 2014 Sep; 66():214-22. PubMed ID: 24956020
[TBL] [Abstract][Full Text] [Related]
13. CD137 induces proliferation of murine hematopoietic progenitor cells and differentiation to macrophages.
Jiang D; Chen Y; Schwarz H
J Immunol; 2008 Sep; 181(6):3923-32. PubMed ID: 18768847
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells.
Yuan X; Qian N; Ling S; Li Y; Sun W; Li J; Du R; Zhong G; Liu C; Yu G; Cao D; Liu Z; Wang Y; Qi Z; Yao Y; Wang F; Liu J; Hao S; Jin X; Zhao Y; Xue J; Zhao D; Gao X; Liang S; Li Y; Song J; Yu S; Li Y
Theranostics; 2021; 11(3):1429-1445. PubMed ID: 33391543
[No Abstract] [Full Text] [Related]
15. CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis.
Li X; Liang Y; Lian C; Peng F; Xiao Y; He Y; Ma C; Wang Y; Zhang P; Deng Y; Su Y; Luo C; Kong X; Yang Q; Liu T; Hu G
Theranostics; 2021; 11(20):9821-9832. PubMed ID: 34815788
[No Abstract] [Full Text] [Related]
16. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
[TBL] [Abstract][Full Text] [Related]
17. Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells.
Glorieux C; Huang P
Cancer Commun (Lond); 2019 Jul; 39(1):41. PubMed ID: 31288851
[TBL] [Abstract][Full Text] [Related]
18. Activation of CD137 signaling accelerates vascular calcification in vivo and vitro.
Chen Y; Bangash AB; Song J; Zhong W; Wang C; Shao C; Wang Z; Yan J
Int J Cardiol; 2017 Mar; 230():198-203. PubMed ID: 28063668
[TBL] [Abstract][Full Text] [Related]
19. RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4.
Nakamura ES; Koizumi K; Kobayashi M; Saitoh Y; Arita Y; Nakayama T; Sakurai H; Yoshie O; Saiki I
Clin Exp Metastasis; 2006; 23(1):9-18. PubMed ID: 16821125
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone.
Sloan EK; Pouliot N; Stanley KL; Chia J; Moseley JM; Hards DK; Anderson RL
Breast Cancer Res; 2006; 8(2):R20. PubMed ID: 16608535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]